Search Results
Results found for "assay development"
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
compounds to delineate the GPR15 receptor-mediated Gα protein signalling using a G protein activation assay and second messenger assay conducted on living cells. results show that the GPR15 receptor preferentially couples to Gi/o rather than other pathways in both assays
- Dr. GPCR University registration is now open! Secure your spot now!
of action for new GPCR ligands Essentials for effective GPCR discovery Discover: Advanced cellular assays therapy to prevent heart failure progression GPCR Binders, Drugs, and more Advances in GPCR-targeted drug development Announces EUR 60M Series B Financing to Advance a Pipeline of Novel GPCR-Modulating Therapies into Clinical Development 7, 2024 | 16th Annual PEGS Europe September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
This has immediate implications for interpreting EC50 shifts, partial agonism, and assay readouts—especially The result is not just cleaner assay design but a sharper decision framework for selecting, prioritizing lets you predict safety margins, dose–response behavior, and translational risk before they derail development
- GPCR Buzz of the Week | Sep 23 - 29, 2024
Registrants will learn: The powerful applications of new cellular assays to determine GPCR ligand behavior Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work in a developing Advisory Board Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety OMass Therapeutics Expands Development
- G protein-coupled receptor 21 in macrophages: An in vitro study
expression was evaluated at gene and protein level, the signalling pathway was investigated by an IP1 assay Cell migration was detected by the Boyden chamber migration assay, performed on macrophages derived from
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
used for a range of different applications, including bioluminescence resonance energy transfer (BRET) assays Here, we report the structure-based development of fluorescent ligands targeting the intracellular allosteric By means of these studies, we developed 14 as a fluorescent CCR2 ligand, enabling cell-free as well as
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
One potential solution is to develop analgesics that act at targets other than opioid receptors. Experimental approach: We used a series of behavioural assays to evaluate the acute responses of mice
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Cryptic Sites, Longer Onset: Why Some Drugs Work Differently in Cells Than in Assays One of the most This has direct implications for: Assay timing and readout design Misclassification of lead candidates
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Cam Sinh Lu , Karen Gregory , Lauren May , Andrea Vernall , et al. for their fantastic paper on Development Registrants will learn: The powerful applications of new cellular assays to determine GPCR ligand behavior Modules: October 31st : The Eyes to See- The Importance of Pharmacologic Assays. Exclusive Deal for Scientists in Developing Nations If you reside and work in a developing country, complete therapeutics N-acyl glycines produced by commensal bacteria potentiate GLP-1 secretion as GPCR ligands Development
- The Adhesion GPCR VLGR1/ADGRV1 Regulates the Ca2+ Homeostasis at Mitochondria-Associated ER Membrane
We confirmed the interaction of VLGR1 with key proteins of MAMs by pull-down assays in vitro complemented by in situ proximity ligation assays in cells.
- Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
In cellular-adhesion assays, LK30 specifically broke the trans-cellular interaction of ADGRL3 with teneurin - and ligand specific aGPCR functions using unique tools, and thus establishes a foundation for the development
- Inside Out: Mapping GPCRs from Membrane Codes to Market Moves
From dual-epitope tagging to scalable multiplex assays, this conversation dives deep into the tools now
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
examines how patient-derived induced pluripotent stem cells (iPSCs), organoid systems, and biosensor-based assays Discovery → Read DiscoverX article A2A Fluorescent Competitive Binding with NanoBRET® → Explore assay
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Whether you’re building assays or a scientific career, this is a must-read on why risk, surprise, and Biosensors make once-invisible dynamics assayable at scale. Read the roundup ➤ Why Dr.
- Unlock the Future of GPCR Science: Breakthroughs and Courses Await | Sep 2 - Sep 8, 2024
Topics: New cellular assays, real-time kinetics, and unique GPCR behaviors. 🔥 Why You Should Enroll Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work in a developing This technique for studying cell receptors could have sweeping implications for drug development DeepCure 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays of Neurological Disease s Activation of GPR55 alleviates neuropathic pain and chronic inflammation Developmental
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
Topics cover new cellular assays, real-time kinetics, and unique GPCR behaviors. 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)
cruciferous vegetables, and insights into regulation of its physiological processes contribute towards the development the Octβ3 protein family, and an analysis using quantitative PCR showed that it was expressed at all developmental The injection of double-stranded RNA in an RNA interference assay indicated that PxOctβ3 regulates development
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
This Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week – Designing Drugs That Anticipate Physiological Pushback Most GPCR programs don’t fail because the assay
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
validate differences, confirm subtle shifts, and benchmark your results against literature or across assay Validate with confidence: Benchmark your results against literature standards and confirm whether your assays
- From One to Many: How a GPCR Curiosity Became a Field-Wide Toolkit
the help of Luminex technology and collaborators at SciLifeLab in Sweden , the lab built a multiplex assay
- Ben Clements on Rescuing Opioids with GPCR Modulators
mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR online course, GTPγS assay
- Unlocking the Future of Medicine: Advancements in GPCR Research
Dates: October 3rd to 31st, 2024 Registrants will learn: The powerful applications of new cellular assays opportunity to connect with like-minded scientists and researchers and gain valuable insights into the latest developments 7, 2024 | 16th Annual PEGS Europe September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
membranes: an alternative to radioligand binding methods "Background: Replacement of radioligand binding assays same order of magnitude but slightly higher than values obtained by the radioligand saturation binding assay
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
resistance, tune selectivity, and design molecules that adapt to real cellular environments—not just ideal assay Bring your toughest pharmacology questions — from receptor bias and assay design to enzyme kinetics — Direct input on future sessions—so topics match the hurdles your team faces in discovery and development
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Delve into new cellular assays, real-time kinetics, and unique GPCR behaviors. 🔥 Why You Should Enroll Special Offer for Scientists who work and live in developing countries If you live and work in a developing News from August 26th to September 1st, 2024 Industry News GPCR-RAMP Interactome Maps Could Help Drug Developers 4th Transatlantic ECI GPCR Symposium September 18, 2024 | FREE Webinar - The value of GPCR cell-based assays
- Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox
Every computational hypothesis moves downstream into experimental assays via close collaborations. Matters Now The convergence of machine learning, improved GPCR structures, and scalable experimental assays
- GPR15 expressed in T lymphocytes from RA patients is involved in leukocyte chemotaxis to the...
in blood and synovial tissue samples from RA patients, as well as to perform a functional migration assay Migration assays were performed using PBMCs isolated from these individuals in response to the synthetic
- Artificial intelligence – faster, smarter, cheaper GPCR drug discovery
The integration of AI in GPCR drug discovery has the potential to accelerate the identification and development Structure: the development of algorithms such DeepMind’s Alphafold2 (Jumper et al., 2021) and RoseTTAFold Open-source data: accessibility of databases to a wider audience will encourage the development of new Efforts will likely be made to develop AI models that can provide transparent explanations for their Precision medicines for GPCRs: AI can facilitate the development of personalized treatments by analyzing
- Pharmacophore-guided Virtual Screening to Identify New β 3 -adrenergic Receptor Agonists
Hence, new β3 -AR agonists are needed as starting points for drug development. To confirm the activity of the virtual hits, an in vitro assay was conducted, measuring cAMP levels at
- Functional Characterization of the Venus Flytrap Domain of the Human TAS1R2 Sweet Taste Receptor
However, cellular assays, molecular docking and site-directed mutagenesis studies have revealed that investigated whether the impact of point mutations, already shown to have deleterious effects on cellular assays


















